3-D Matrix, Ltd. (DMTRF) Research

3-D Matrix, Ltd. specializes in advancing self-assembling peptide technology. The company's primary offering is PuraMatrix, an innovative self-assembling peptide hydrogel utilized across diverse medical sectors such as regenerative medicine, cell-based therapies, sophisticated drug delivery mechanisms, and various surgical applications. This Tokyo, Japan-based entity was founded in 2004.

Market snapshot

Symbol
DMTRF
Price
$2.25
Day change
0.00%
Market cap
$38.5B
P/E ratio
9.43x
52-week range
0.69-3.96
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 3 months

Peer companies

  • Alterola Biotech, Inc. (ABTI)
  • American Oncology Network, Inc. (AONC)
  • Cellectis S.A. (CMVLF)
  • Euroapi S.A. (EAPIF)
  • Spectral Medical Inc. (EDTXF)
  • Hansa Biopharma AB (publ) (HNSBF)
  • Integrated Diagnostics Holdings plc (IDGXF)
  • Mayne Pharma Group Limited (MAYNF)

Open 3-D Matrix, Ltd. (DMTRF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.